HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytostatic Agents

Compounds that inhibit or prevent the proliferation of CELLS.
Also Known As:
Cytostatic Drugs; Cytostatics; Agent, Cytostatic; Drug, Cytostatic; Cytostatic; Cytostatic Agent; Cytostatic Drug
Networked: 6779 relevant articles (293 outcomes, 567 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Balzarini, Jan: 38 articles (01/2018 - 12/2003)
2. Kiss, Robert: 22 articles (02/2018 - 04/2003)
3. Mathieu, Véronique: 17 articles (02/2018 - 11/2010)
4. Orbán, Erika: 13 articles (06/2016 - 01/2009)
5. De Clercq, Erik: 13 articles (01/2016 - 12/2003)
6. Lefranc, Florence: 12 articles (02/2018 - 04/2003)
7. Manea, Marilena: 12 articles (12/2015 - 04/2009)
8. Raić-Malić, Silvana: 11 articles (11/2021 - 12/2003)
9. Razina, T G: 10 articles (06/2022 - 01/2003)
10. Wietrzyk, Joanna: 10 articles (12/2020 - 01/2007)

Related Diseases

1. Neoplasms (Cancer)
2. Breast Neoplasms (Breast Cancer)
3. Leukemia
11/01/1975 - "Furthermore the striking difference in spontaneous labelling of myeloid versus lymphoblastic leukemic cells seems to be helpful in the differential diagnosis and may in part explain the well known differences in prognosis and behaviour towards cytostatics between these main leukemia types."
01/01/1990 - "Insight has been obtained with regard to the kinetics of MRD; the efficacy of certain treatment modalities, e.g., cytostatic drug treatment with or without total body irradiation to eradicate MRD; the efficacy of various methods for eliminating residual leukemic cells from autologous marrow grafts; the emergence of drug resistance during MRD; and the progression of residual disease during the remission phase ultimately leading to a relapse and the implications of these observations for staging leukemia patients during the phase of MRD."
01/01/1988 - "It has been found that with the target cell K-562: granulocyte ratio of 1:20, the normal granulocytes inhibit the K-562 cell growth by 44.3 +/- 3.1% at 37 degrees C within 42 h; in patients with acute leukemia in the acute phase of the disease the cytostatic activity is greatly lowered, while in remission up to two years it increases, however, without reaching the normal values. "
01/01/1987 - "When remission was obtained, bone marrow plasmocytosis was similar to normal controls, irrespective of the type of acute leukemia and the cytostatic treatment. "
01/01/1980 - "Therefore the possibility to predict which cytostatic combination should be abandoned because it will not lead to a remission was studied in 58 leukemia patients. "
4. Neoplasm Metastasis (Metastasis)
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. Doxorubicin (Adriamycin)
2. Cyclophosphamide (Cytoxan)
3. Pharmaceutical Preparations
4. Cisplatin (Platino)
5. Paclitaxel (Taxol)
6. Monoclonal Antibodies
7. Antineoplastic Agents (Antineoplastics)
8. Fluorouracil (Carac)
9. DNA (Deoxyribonucleic Acid)
10. Cytotoxins (Cytolysins)

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Radiotherapy
4. Combination Drug Therapy (Combination Chemotherapy)
5. Aftercare (After-Treatment)